Silexion Therapeutics Corp - 8-K Filing
Silexion Therapeutics shareholders approve 500 million share capital increase and a 1-for-24 reverse stock split. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 5.07 below, 9.01 Financial Statements and Exhibits)
Tickers: $SLXN